Literature DB >> 8225459

Five-year statistical and clinical observations with the IMZ two-stage osteointegrated implant system.

C A Babbush1, M Shimura.   

Abstract

This study evaluated patients who were reconstructed with the IMZ system, which consists of a cylindrical implant with an intramobile element for stress relief. It is placed through a two-stage surgical procedure resulting in osteointegration. During a 5-year period, 1,059 implants were placed in 322 patients. Twenty-one implants were lost to follow-up. A total of 28 implants failed over the 5-year period, of which 9 had not integrated at stage 2 surgery. Of the remaining implants, 19 failed primarily for periodontal and prosthetic reasons. The life table method was used for statistical analysis. The 5-year survival rate of all IMZ implants was 95%. Seventy-five percent of the implants were placed to restore partial edentulism, with a survival rate of 96%. The survival rate for totally edentulous patients was also 96%. Forty-four percent of the implants were placed in the maxilla, with a survival rate of 92%. The survival rate in the mandible was 99%. Sixty-six percent of the implants were placed in women, with a survival rate of 94%. The survival rate in men was 98%. Major factors that positively influenced long-term survival were use of the longest and largest-diameter implants appropriate for the clinical situation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8225459

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Implants        ISSN: 0882-2786            Impact factor:   2.804


  1 in total

1.  Dental Implant Failure Risk in Post Oncological Patients, a Retrospective Study and Sapienza Head and Neck Unit Decisional Protocol- 7 Years of Follow-Up.

Authors:  Edoardo Brauner; Valentino Valentini; Umberto Romeo; Marco Cantore; Federico Laudoni; Oriana Rajabtork Zadeh; Valeria Formisano; Andrea Cassoni; Marco Della Monaca; Andrea Battisti; Silvia Mezi; Alessio Cirillo; Francesca De Felice; Andrea Botticelli; Vincenzo Tombolini; Marco De Vincentiis; Andrea Colizza; Gianluca Tenore; Antonella Polimeni; Stefano Di Carlo
Journal:  Diagnostics (Basel)       Date:  2022-08-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.